CELLUFRESH

This brand name is authorized in Australia, Spain, South Africa

Active ingredients

The drug CELLUFRESH contains one active pharmaceutical ingredient (API):

1 Carmellose sodium UNII K679OBS311 - CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED

Carmellose sodium has no pharmacological effect. Carmellose sodium has a high viscosity resulting in an increased retention time on the eye. Read about Carmellose

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01XA20	Artificial tears and other indifferent preparations	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2338C, 5506T
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61009
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/15.4/0477